Vitamin D-related polymorphisms and vitamin D levels as risk biomarkers of COVID-19 disease severity
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Outros Autores: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | https://hdl.handle.net/10216/149595 |
Resumo: | Vitamin D is a fundamental regulator of host defences by activating genes related to innate and adaptive immunity. Previous research shows a correlation between the levels of vitamin D in patients infected with SARS-CoV-2 and the degree of disease severity. This work investigates the impact of the genetic background related to vitamin D pathways on COVID-19 severity. For the first time, the Portuguese population was characterized regarding the prevalence of high impact variants in genes associated with the vitamin D pathways. This study enrolled 517 patients admitted to two tertiary Portuguese hospitals. The serum concentration of 25 (OH)D, was measured in the hospital at the time of patient admission. Genetic variants, 18 variants, in the genes AMDHD1, CYP2R1, CYP24A1, DHCR7, GC, SEC23A, and VDR were analysed. The results show that polymorphisms in the vitamin D binding protein encoded by the GC gene are related to the infection severity (p = 0.005). There is an association between vitamin D polygenic risk score and the serum concentration of 25 (OH)D (p = 0.04). There is an association between 25 (OH)D levels and the survival and fatal outcomes (p = 1.5e−4). The Portuguese population has a higher prevalence of the DHCR7 RS12785878 variant when compared with its prevalence in the European population (19% versus 10%). This study shows a genetic susceptibility for vitamin D deficiency that might explain higher severity degrees in COVID-19 patients. These results reinforce the relevance of personalized strategies in the context of viral diseases. |
id |
RCAP_30bd156083407f72f98c10a954003f7e |
---|---|
oai_identifier_str |
oai:repositorio-aberto.up.pt:10216/149595 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Vitamin D-related polymorphisms and vitamin D levels as risk biomarkers of COVID-19 disease severityImmunogeneticsPredictive markersRisk factorsViral infectionVitamin D is a fundamental regulator of host defences by activating genes related to innate and adaptive immunity. Previous research shows a correlation between the levels of vitamin D in patients infected with SARS-CoV-2 and the degree of disease severity. This work investigates the impact of the genetic background related to vitamin D pathways on COVID-19 severity. For the first time, the Portuguese population was characterized regarding the prevalence of high impact variants in genes associated with the vitamin D pathways. This study enrolled 517 patients admitted to two tertiary Portuguese hospitals. The serum concentration of 25 (OH)D, was measured in the hospital at the time of patient admission. Genetic variants, 18 variants, in the genes AMDHD1, CYP2R1, CYP24A1, DHCR7, GC, SEC23A, and VDR were analysed. The results show that polymorphisms in the vitamin D binding protein encoded by the GC gene are related to the infection severity (p = 0.005). There is an association between vitamin D polygenic risk score and the serum concentration of 25 (OH)D (p = 0.04). There is an association between 25 (OH)D levels and the survival and fatal outcomes (p = 1.5e−4). The Portuguese population has a higher prevalence of the DHCR7 RS12785878 variant when compared with its prevalence in the European population (19% versus 10%). This study shows a genetic susceptibility for vitamin D deficiency that might explain higher severity degrees in COVID-19 patients. These results reinforce the relevance of personalized strategies in the context of viral diseases.Nature Research20212021-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://hdl.handle.net/10216/149595eng2045-232210.1038/s41598-021-99952-zFreitas, ATCalhau, CAntunes, GAraújo, BBandeira, MBarreira, SBazenga, FBraz, SCaldeira, DSantos, SCRFaria, AFaria, DFraga, MNogueira-Garcia, BGonçalves, LKovalchuk, PLacerda LLopes, HLuís, DMedeiros, FMelo, AMPMelo-Cristino, JMiranda, APereira, CPinto, ATPinto, JProença, HRamos, ARato, JPRRocha, FRocha, JCMoreira-Rosário, AVazão, HVolovetska, YGuimarães, JTPinto, FJinfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-11-29T13:47:05Zoai:repositorio-aberto.up.pt:10216/149595Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T23:47:30.780487Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Vitamin D-related polymorphisms and vitamin D levels as risk biomarkers of COVID-19 disease severity |
title |
Vitamin D-related polymorphisms and vitamin D levels as risk biomarkers of COVID-19 disease severity |
spellingShingle |
Vitamin D-related polymorphisms and vitamin D levels as risk biomarkers of COVID-19 disease severity Freitas, AT Immunogenetics Predictive markers Risk factors Viral infection |
title_short |
Vitamin D-related polymorphisms and vitamin D levels as risk biomarkers of COVID-19 disease severity |
title_full |
Vitamin D-related polymorphisms and vitamin D levels as risk biomarkers of COVID-19 disease severity |
title_fullStr |
Vitamin D-related polymorphisms and vitamin D levels as risk biomarkers of COVID-19 disease severity |
title_full_unstemmed |
Vitamin D-related polymorphisms and vitamin D levels as risk biomarkers of COVID-19 disease severity |
title_sort |
Vitamin D-related polymorphisms and vitamin D levels as risk biomarkers of COVID-19 disease severity |
author |
Freitas, AT |
author_facet |
Freitas, AT Calhau, C Antunes, G Araújo, B Bandeira, M Barreira, S Bazenga, F Braz, S Caldeira, D Santos, SCR Faria, A Faria, D Fraga, M Nogueira-Garcia, B Gonçalves, L Kovalchuk, P Lacerda L Lopes, H Luís, D Medeiros, F Melo, AMP Melo-Cristino, J Miranda, A Pereira, C Pinto, AT Pinto, J Proença, H Ramos, A Rato, JPR Rocha, F Rocha, JC Moreira-Rosário, A Vazão, H Volovetska, Y Guimarães, JT Pinto, FJ |
author_role |
author |
author2 |
Calhau, C Antunes, G Araújo, B Bandeira, M Barreira, S Bazenga, F Braz, S Caldeira, D Santos, SCR Faria, A Faria, D Fraga, M Nogueira-Garcia, B Gonçalves, L Kovalchuk, P Lacerda L Lopes, H Luís, D Medeiros, F Melo, AMP Melo-Cristino, J Miranda, A Pereira, C Pinto, AT Pinto, J Proença, H Ramos, A Rato, JPR Rocha, F Rocha, JC Moreira-Rosário, A Vazão, H Volovetska, Y Guimarães, JT Pinto, FJ |
author2_role |
author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Freitas, AT Calhau, C Antunes, G Araújo, B Bandeira, M Barreira, S Bazenga, F Braz, S Caldeira, D Santos, SCR Faria, A Faria, D Fraga, M Nogueira-Garcia, B Gonçalves, L Kovalchuk, P Lacerda L Lopes, H Luís, D Medeiros, F Melo, AMP Melo-Cristino, J Miranda, A Pereira, C Pinto, AT Pinto, J Proença, H Ramos, A Rato, JPR Rocha, F Rocha, JC Moreira-Rosário, A Vazão, H Volovetska, Y Guimarães, JT Pinto, FJ |
dc.subject.por.fl_str_mv |
Immunogenetics Predictive markers Risk factors Viral infection |
topic |
Immunogenetics Predictive markers Risk factors Viral infection |
description |
Vitamin D is a fundamental regulator of host defences by activating genes related to innate and adaptive immunity. Previous research shows a correlation between the levels of vitamin D in patients infected with SARS-CoV-2 and the degree of disease severity. This work investigates the impact of the genetic background related to vitamin D pathways on COVID-19 severity. For the first time, the Portuguese population was characterized regarding the prevalence of high impact variants in genes associated with the vitamin D pathways. This study enrolled 517 patients admitted to two tertiary Portuguese hospitals. The serum concentration of 25 (OH)D, was measured in the hospital at the time of patient admission. Genetic variants, 18 variants, in the genes AMDHD1, CYP2R1, CYP24A1, DHCR7, GC, SEC23A, and VDR were analysed. The results show that polymorphisms in the vitamin D binding protein encoded by the GC gene are related to the infection severity (p = 0.005). There is an association between vitamin D polygenic risk score and the serum concentration of 25 (OH)D (p = 0.04). There is an association between 25 (OH)D levels and the survival and fatal outcomes (p = 1.5e−4). The Portuguese population has a higher prevalence of the DHCR7 RS12785878 variant when compared with its prevalence in the European population (19% versus 10%). This study shows a genetic susceptibility for vitamin D deficiency that might explain higher severity degrees in COVID-19 patients. These results reinforce the relevance of personalized strategies in the context of viral diseases. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021 2021-01-01T00:00:00Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://hdl.handle.net/10216/149595 |
url |
https://hdl.handle.net/10216/149595 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
2045-2322 10.1038/s41598-021-99952-z |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Nature Research |
publisher.none.fl_str_mv |
Nature Research |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799135792987111424 |